AbbVie (ABBV)
(Delayed Data from NYSE)
$169.42 USD
+0.85 (0.50%)
Updated Jun 7, 2024 04:00 PM ET
After-Market: $169.97 +0.55 (0.32%) 7:58 PM ET
3-Hold of 5 3
C Value C Growth F Momentum C VGM
Brokerage Reports
0 items in cart
AbbVie Inc. [ABBV]
Reports for Purchase
Showing records 181 - 200 ( 380 total )
Company: AbbVie Inc.
Industry: Large Cap Pharmaceuticals
Comprehensive Technical and Fundamental Analysis for ABBV.
Provider: Stock Traders Daily
Analyst: Research Department
Company: AbbVie Inc.
Industry: Large Cap Pharmaceuticals
Weekly Retail Sales Tracker for Hem. Malignancies - Week Ended May 14
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: AbbVie Inc.
Industry: Large Cap Pharmaceuticals
Weekly Retail Sales Tracker for Hem. Malignancies - Week Ended May 7
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: AbbVie Inc.
Industry: Large Cap Pharmaceuticals
Provider: Zacks Investment Research
Analyst: Research Department
Company: AbbVie Inc.
Industry: Large Cap Pharmaceuticals
Weekly Retail Sales Tracker for Hem. Malignancies - Week Ended April 30
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: AbbVie Inc.
Industry: Large Cap Pharmaceuticals
Weekly Retail Sales Tracker for Hem. Malignancies
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: AbbVie Inc.
Industry: Large Cap Pharmaceuticals
Key Takeaways From Our Coverage at the American Academy of Neurology 2021 Virtual Meeting
Provider: H.C. Wainwright & Co., Inc.
Analyst: TSAO D
Company: AbbVie Inc.
Industry: Large Cap Pharmaceuticals
Weekly Retail Sales Tracker for Hem. Malignancies - Week Ended April 16
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: AbbVie Inc.
Industry: Large Cap Pharmaceuticals
Weekly Retail Sales Tracker for Hem. Malignancies - Week Ended April 9
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: AbbVie Inc.
Industry: Large Cap Pharmaceuticals
Provider: Zacks Investment Research
Analyst: Research Department
Company: AbbVie Inc.
Industry: Large Cap Pharmaceuticals
Weekly Retail Sales Tracker for Hem. Malignancies - Week Ended March 19
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: AbbVie Inc.
Industry: Large Cap Pharmaceuticals
Weekly Retail Sales Tracker for Hem. Malignancies - Week Ended March 12
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: AbbVie Inc.
Industry: Large Cap Pharmaceuticals
Weekly Retail Sales Tracker for Hem. Malignancies - Week Ended March
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: AbbVie Inc.
Industry: Large Cap Pharmaceuticals
Provider: Zacks Investment Research
Analyst: Research Department
Company: AbbVie Inc.
Industry: Large Cap Pharmaceuticals
Weekly Retail Sales Tracker for Hem. Malignancies - Week Ended February 12
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: AbbVie Inc.
Industry: Large Cap Pharmaceuticals
Provider: Zacks Investment Research
Analyst: Research Department
Company: AbbVie Inc.
Industry: Large Cap Pharmaceuticals
Weekly Retail Sales Tracker for Hem. Malignancies - Week Ended January 22
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: AbbVie Inc.
Industry: Large Cap Pharmaceuticals
Weekly Retail Sales Tracker for Hem. Malignancies - Week Ended January 15
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: AbbVie Inc.
Industry: Large Cap Pharmaceuticals
Provider: Zacks Investment Research
Analyst: Research Department
Company: AbbVie Inc.
Industry: Large Cap Pharmaceuticals
Weekly Retail Sales Tracker for Hem. Malignancies - Week Ended January 8
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D